Navigation Links
New Prime Therapeutics Study Finds Antiviral Medications Were Not Hoarded During H1N1 Flu Season
Date:5/20/2010

ST. PAUL, Minn., May 20 /PRNewswire/ -- Despite concerns from public health officials, influenza antiviral drugs were not hoarded during the recent H1N1 flu season, according to a new analysis presented recently at the Academy of Managed Care Pharmacy's 22nd Annual Meeting in San Diego by Prime Therapeutics (Prime), a thought leader in pharmacy benefit management.

For the study, researchers from Prime and one of its Blue Cross Blue Shield (BCBS) clients compared the use of influenza antiviral drugs during the H1N1 season to antiviral use during past flu seasons. The H1N1 global pandemic was declared in June 2009, and the U.S. Centers for Disease Control (CDC) recommended that patients at high risk of a complication, or those suspected of influenza and with more serious symptoms, receive antiviral medications. Amidst public concern about the pandemic, public health officials warned against hoarding of antiviral medication.

Researchers examined antiviral use among nine million members enrolled in commercial health plans across 11 states between September 2006 and December 2009 to determine the frequency of high-quantity and multiple-refill oseltamivir (a common influenza antiviral drug) claims among different geographic regions. While there was variability in antiviral use across geographic regions, use of antivirals during the H1N1 season was comparable to past flu seasons, and there was little indication of hoarding.

The study was designed to evaluate whether a utilization management program might increase patient safety and control costs. Researchers concluded that the impact of an antiviral quantity limit program would be limited given the low prevalence of high-quanti
'/>"/>

SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Greenway Medical Technologies PrimeSuite Wins Three Best in KLAS Awards
2. Greenway Medical Technologies PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification
3. Prime Therapeutics Receives 2010 TIPPS Certification for Adherence to High Transparency Standards
4. Alzheimers Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology
5. Orexigen(R) Therapeutics Schedules May 10, 2010 Webcast Discussion of Financial Results for the First Quarter Ended March 31, 2010
6. Osseon Therapeutics Demonstrates to the European Medical Community How to Think Outside The Balloon When Treating Vertebral Compression Fractures
7. Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010
8. Cornerstone Therapeutics To Present at Deutsche Banks 35th Annual Healthcare Conference
9. Logical Therapeutics Initiates Enrollment in New Gastrointestinal Safety Study in Osteoarthritis Patients
10. Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes
11. Cornerstone Therapeutics to Host First Quarter 2010 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... Jan. 14, 2014 InformEx, North America,s ... high-value chemistry, will hold the 30 th edition of ... Convention Center from January 21-24. (Logo: ... top pharmaceutical, fine chemical and specialty chemical companies will take ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... , ... Therapeutics, Inc. (PTC) today announced the initiation of an additional ... with nonsense mutation Duchenne/ Becker muscular dystrophy (nmDBMD) who ... is evaluating the best methods for measuring functional abilities in ...
... , VENLO, The Netherlands , Jan. 18 ... by the Lancet Oncology found that testing for high-risk types ... invasive cervical cancer than cytology (Pap testing) alone. The trial used QIAGEN,s ... HC2 HPV DNA Test), which detects the high-risk types of HPV that ...
Cached Medicine Technology:PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 2PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 3PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 4PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 5PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 6Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 2Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 3Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 4Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 5Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 6
(Date:4/16/2014)... 15, 2014 The Translational Genomics Research Institute (TGen) ... Founders Dinner for their support of TGen,s research into ... March 28 in Scottsdale. , Catherine Ivy, Founder and ... TGen,s John S. McCain Leadership Award, named for U.S. ...
(Date:4/16/2014)... While it is well known that fertility treatments are ... that multiples are at elevated risk of premature birth, ... Fertility and Sterility . The article ... reduce the odds of multiple births and prematurity, including ...
(Date:4/15/2014)... a recent analysis by the RECIST Working Group published in ... explored whether a more refined categorization of tumor response or ... in the RECIST database. They found that modeling target ... survival above and beyond that of the other components of ...
(Date:4/14/2014)... Ford Hospital reached a medical milestone April 3, performing ... way to access the heart. , Henry Ford is ... unique procedure called transcaval valve replacement, which accesses the ... Michigan resident Viola Waller, 80, underwent Henry Ford,s first ...
(Date:4/14/2014)... treatment decisions leaves cancer patients feeling more satisfied with ... the experience, researchers from the Perelman School of ... the journal Cancer . , In a study ... MD , an associate professor in the department in ...
Breaking Medicine News(10 mins):Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3Health News:Can refined categorization improve prediction of patient survival in RECIST 1.1? 2Health News:Henry Ford Hospital hits new heart valve surgery milestone 2Health News:Shared decision making during radiation therapy improves patient satisfaction 2Health News:Shared decision making during radiation therapy improves patient satisfaction 3
... Day (Dec 1), India will launch a new scheme to ... Anbumani Ramadoss said here Monday. // ,"On Nov 30, ... treatment for children using paediatric anti-retroviral (ARV) drugs. We have ... four pharmaceutical companies are part of the process," Ramadoss told ...
... the United Kingdom concluded that the UK's National Health ... least// for now. The review was published in the ... series of the Health Technology Assessment Programme, part of ... Kingdom. ,An implantable pump can help heart ...
... indicates future heart problems, according to a study.,This research ... Journal of the American College of Cardiology. ... having a heart attack are at greater risk for ... depression-related screening protocols and treatment strategies. ,Known ...
... a familiar giant. Smokers around the world find it hard ... buy time by assuming that, cutting// down on the number ... latest research disagrees. ,A study published by ‘Tobacco Control’ ... number of cigarettes you smoke or continue to smoke 15 ...
... Pharma Ltd, based in Hyderabad, India, has announced the launch ... treat certain types of lung cancer. A very costly// preparation, ... imported version of the same medication, costs a whopping Rs ... first ever generic version of Pemetrexed, in the global arena. ...
... system has been developed that surpasses mammography in detecting ... had developed the system and the// University has licensed ... to make, use and sell the scanners. The National ... the Development. ,While commenting on the new ...
Cached Medicine News:Health News:Free HIV Treatment to Be Launched for Children 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 3Health News:Depression After Heart Attack Means More Heart Problems 2Health News:Depression After Heart Attack Means More Heart Problems 3Health News:For Smokers Only: is Quitting = Cutting Down?? a 'grave' Issue 2Health News:New Imaging System Surpasses Mammography In Detecting Breast Cancer 2
... From the Pioneer in Digital EEG ... Digital EEG system presents the latest ... the Ceegraph VISION. This innovative system ... remote communications and information management to ...
"Ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Complies with international standards of electrophysiology....
The field of application of the SL 120 Slit Lamp extends from the anterior ocular segment and the vitreous right back to the fundus. It is the ideal configuration for observation, measurement, diagno...
Lens Loading and Folding for Multipiece & Single-Piece ACRYSOF Lens with Standard Forceps...
Medicine Products: